PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
PolyPid has raised €44M across 1 funding round, most recently a Series D+ round in Jul 2019. Based in Petah Tiqva, Israel; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series D+ | €44M |
| — |
| View deal → |
